U.S. federal trademark · Serial No. 87482451
Medical services, namely, identification of contraindicated drugs and drug-to-drug interactions, and examination of drugs most commonly used in cancer treatment to allow doctors to modify and tailor specific medications based on chemotherapeutics, creating personalized medicine options for patients
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.